bpc-157 safety studies humans and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded What Is BPC-157: Benefits, Uses
Description
(2017) and Natale et al

The absence of patent protection with clear commercial pathways has limited pharmaceutical industry investment in advancing either compound through full clinical development, despite the availability of clinical data for CJC-1295 (DAC version) demonstrating safety and efficacy signals in Phase I/II studies

Cold exposure is a clean, well-studied state reset, not a cure for inflammation
The main symptoms include: Physical fatigue : a constant feeling of exhaustion that does not go away even after adequate rest or sleep